SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Alexion Pharmaceuticals, Inc. (ALXN)

Add ALXN Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/28/2017 6:07:27 PM - Followers: 5 - Board type: Free - Posts Today: 0

Alexion Pharmaceuticals, Inc., a biotechnology company, develops and delivers life-changing drug therapies for patients with serious and life-threatening medical conditions. It primarily engages in the discovery, development, and commercialization of biologic therapeutic products for the treatment of severe disease states, including hematologic diseases, cancer, and autoimmune disorders. The company markets Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disorder in the United States and Europe. It also is evaluating other potential indications for Soliris, as well as other formulations of eculizumab for additional clinical indications. In addition, it is developing antibody product candidates targeting the treatment of patients with severe unmet medical needs. The company's drug programs comprise DC-SIGN Mab, a cancer Vaccine; Eculizumab (intravitreal) for age-related macular degeneration; and Eculizumab (intravenous) for myasthenia gravis and multifocal motor neuropathy, which are under preclinical development stage; CD200 Mab for the treatment of chronic lymphocytic leukemia and multiple myeloma under Phase I clinical trial; and Eculizumab (intravenous) under Phase I/II clinical trial for the treatment of asthma. . Alexion Pharmaceuticals was founded in 1992 and is headquartered in Cheshire, Connecticut.



Headquartered in Cheshire, Connecticut, Alexion employs more than 700 people around the world. In addition to our corporate headquarters, Alexion’s facilities include a manufacturing plant in Smithfield, Rhode Island, EMEA (Europe, Middle East & Africa) regional headquarters in Lausanne, Switzerland, a European shared service center in Paris, distribution and sales operations in major markets throughout Europe, and new operations in Tokyo, Japan, Sydney, Australia, São Paulo, Brazil, Ontario, Canada and other countries. The company is also expanding its reach in Latin America, the Middle East and Africa.

Alexion’s global presence reflects the approval of Soliris for the treatment of patients with PNH in the United States, 29 European countries, Australia, Canada and other countries. The company is working toward seeking regulatory approval in other countries of Asia and South America.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ALXN News: Current Report Filing (8-k) 05/23/2017 04:22:36 PM
ALXN News: Alexion Announces Executive Leadership Changes 05/23/2017 08:00:00 AM
ALXN News: Rady Children’s Institute for Genomic Medicine & Alexion Pharmaceuticals Partner to Speed the Diagnosis of Rare Genetic Dis... 05/16/2017 06:30:00 AM
ALXN News: Long-term Data Confirm Benefits of Treatment with Strensiq® (asfotase alfa) in Adolescents & Adults with Hypophosphatasia (H... 05/15/2017 08:00:00 AM
ALXN News: Statement of Changes in Beneficial Ownership (4) 05/12/2017 06:03:45 PM
#122   They always say buy before leaving a sinking Dr_Thorfin 05/28/17 06:07:27 PM
#120   newbs sellingggg. big $$ to be made here! Dutchdaan 05/26/17 04:10:34 PM
#119   Where is Alexion Pharmaceuticals' stock going? Where will Dutchdaan 05/26/17 04:10:00 PM
#118   Adam Feuerstein, martin and goldman say buy its Dutchdaan 05/26/17 03:52:38 PM
#117   With nothing good in their pipeline and their Inthe203 05/26/17 03:45:43 PM
#116   see you at $200 in 6 months BRO Dutchdaan 05/26/17 03:12:13 PM
#115   I know, peanut. Rare to buy into Inthe203 05/26/17 03:09:55 PM
#114   no i just started buying last week. and Dutchdaan 05/26/17 03:05:42 PM
#113   Sure :) Inthe203 05/26/17 03:01:08 PM
#112   $ALXN lol green close coming!! this is going Dutchdaan 05/26/17 01:44:53 PM
#111   ASK THE CEO FOR A HEAD COUNT OF EMPLOYEES! Inthe203 05/26/17 12:09:12 PM
#109   Let's focus, peanut. Inthe203 05/25/17 04:09:05 PM
#108   Sure. and their batteries last for weeks right? Dutchdaan 05/25/17 03:48:28 PM
#107   I made over 680K on that stock. Inthe203 05/25/17 03:43:41 PM
#106   you just keep buying dolv.thinking it is the Dutchdaan 05/25/17 03:42:17 PM
#105   yes i do. Dutchdaan 05/25/17 03:36:20 PM
#104   You're going to put weight into the words Inthe203 05/25/17 02:53:12 PM
#103   Newb martin Shkreli and goldman both say it Dutchdaan 05/25/17 01:53:45 PM
#102   Stop pumping this stock. Inthe203 05/25/17 10:31:04 AM
#101   it is undervalued at this point. way undervalued Dutchdaan 05/25/17 03:33:15 AM
#100   SELL YOUR SHARES!!! Inthe203 05/24/17 08:21:22 PM
#99   THIS COMPANY IS TANKING.. NOT A BUY! Inthe203 05/24/17 08:15:45 PM
#98   100% buy at these level! Dutchdaan 05/15/17 08:16:11 AM
#97   ALXN's Soliris is administered by a 2 hour Dr_Thorfin 03/17/17 02:51:22 AM
#96   Alexion is scheduled to report earnings on Thursday. ValueInvestor15 02/12/17 03:19:16 PM
#95 Dr_Thorfin 01/18/17 11:00:12 AM
#94 Dr_Thorfin 01/18/17 10:59:36 AM
#93 Dr_Thorfin 01/18/17 10:59:34 AM
#92   $31 BILLION FRAUD WITH $3.5 BILLION DEBT AND Bernstein 01/05/17 10:05:58 AM
#91   $ALXN being shorted to death today......shorties are going runningwithscissors 12/12/16 02:13:52 PM
#90   reloaded calls when it dipped to $111....looking for runningwithscissors 12/12/16 01:43:26 PM
#89   An 11 year veteran CFO from Honeywell would aasma 12/12/16 10:46:49 AM
#88   Totally oversold. look for this whole loss to aasma 12/12/16 10:42:11 AM
#87   Cheap January $100 priced calls on panic selloff runningwithscissors 12/12/16 10:35:06 AM
#86   BUYOUT RUMORS Inthe203 11/04/16 06:53:24 PM
#85   ALXN bullish 132.135 stocktrademan 08/19/16 04:16:42 PM
#84   HEADS UP! BUYOUT/HOSTILE TAKEOVER! Inthe203 06/26/16 02:44:13 PM
#83   Here’s Our Highlight From the Latest Alexion Pharmaceuticals venturecapp 05/04/16 01:10:49 PM
#82   Here’s how to get an Exposure to Moderna’s trendmkr 01/12/16 12:09:08 PM
#81   U.S JUSTICE DEPARTMENT INVESTIGATING ALEXION nyc212investor 11/04/15 12:12:29 PM
#80   A look at the charts for you.... 123tom 10/29/15 03:04:11 PM
#79   Tomorow is all about the financials. nyc212investor 10/28/15 12:53:54 PM
#78   KANUMA DRUG TO BE APPROVED nyc212investor 10/23/15 05:32:15 PM
#77   ALEXION LOOKING TO EXPAND nyc212investor 10/23/15 05:28:10 PM
#76   CONGRATULATIONS ALEXION! nyc212investor 10/23/15 05:22:08 PM
#75   $ALXN recent news/filings stocktrademan 05/08/15 10:21:03 AM
#74   I still believe they'll do well in the Axel 05/07/15 05:13:38 AM
#73   Major beat down today! Overpaid for GEVA. crudeoil24 05/06/15 09:45:21 AM
#72   Hell of a chart here! 90% success when Axel 05/02/15 04:06:28 PM
#71   Closed above 190. > ALL TIME HIGH! crudeoil24 10/24/14 06:13:03 PM